Previous Close | 474.74 |
Open | 474.74 |
Bid | 478.61 x 100 |
Ask | 479.22 x 100 |
Day's Range | 468.46 - 479.51 |
52 Week Range | 341.85 - 510.64 |
Volume | |
Avg. Volume | 1,152,304 |
Market Cap | 123.541B |
Beta (5Y Monthly) | 0.41 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.99 |
Earnings Date | Nov 04, 2024 - Nov 08, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 513.97 |
VRTX is a good stock to have in one's portfolio based on its strong overall financial performance and robust pipeline progress.
In the most recent trading session, Vertex Pharmaceuticals (VRTX) closed at $470.78, indicating a -0.07% shift from the previous trading day.
We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against the other biotech stocks. As we have mentioned in our article, “10 Best Penny Stocks to Buy Under $1,” the […]